Do Not Combine Lantus with Humulin 70/30
This combination is inappropriate and should not be prescribed. Combining a long-acting basal insulin (Lantus/insulin glargine) with a premixed insulin (Humulin 70/30) creates overlapping basal insulin coverage that significantly increases hypoglycemia risk without providing rational glycemic control.
Why This Combination Is Problematic
Overlapping Basal Insulin Coverage
- Humulin 70/30 already contains 70% NPH insulin, which provides intermediate-acting basal coverage lasting 12-16 hours when given twice daily
- Lantus provides 24-hour basal coverage with its flat, peakless profile 1
- Using both creates redundant and excessive basal insulin, dramatically increasing hypoglycemia risk, particularly overnight
Contradicts Evidence-Based Guidelines
The 2025 ADA Standards of Care explicitly outline appropriate insulin intensification pathways 2:
- If bedtime NPH (similar to the NPH component in 70/30) is insufficient, the guideline recommends converting to twice-daily NPH or adding prandial insulin—not adding a second basal insulin
- When transitioning from NPH to basal analogs like Lantus, the guideline recommends using 80% of the total NPH dose, implying replacement rather than addition
Appropriate Insulin Regimens
Option 1: Humulin 70/30 Twice Daily Alone
- Provides both basal (NPH component) and prandial (regular insulin component) coverage
- Simpler regimen with fewer injections
- Appropriate for patients with regular meal schedules
Option 2: Lantus Once Daily + Prandial Insulin
- Lantus 12 units at bedtime for basal coverage
- Add rapid-acting insulin (lispro, aspart) or regular insulin before meals for prandial coverage 2
- Start with 4 units or 10% of basal dose at the largest meal 2
- Provides more flexibility for irregular meal timing
Option 3: NPH-Based Regimen (If Cost Is a Concern)
- Twice-daily NPH with regular insulin before meals
- Can use self-mixed combinations to reduce injection frequency 2
- Less expensive than analog insulins while maintaining efficacy 1
Clinical Decision Algorithm
If the patient is currently on Lantus alone and needs intensification:
- Add prandial insulin (rapid-acting or regular) with the largest meal first 2
- If A1C remains above goal, add prandial insulin to additional meals
- Consider GLP-1 RA if not already prescribed 2
If the patient needs a simpler regimen:
- Switch to Humulin 70/30 twice daily (discontinue Lantus)
- Use 2/3 of total daily dose before breakfast, 1/3 before dinner 2
If the patient has irregular meal schedules:
- Use Lantus once daily for basal coverage
- Add rapid-acting insulin before each meal as needed
Key Safety Considerations
Hypoglycemia Risk
- The proposed combination would create unpredictable insulin stacking, especially during overnight hours when both the NPH component of 70/30 and Lantus are active
- FDA labeling for Lantus demonstrates comparable hypoglycemia rates to NPH when used appropriately—not in combination 1
Lack of Physiologic Rationale
- Endogenous insulin secretion provides one continuous basal level plus meal-time boluses
- The proposed regimen provides two overlapping basal insulins plus prandial coverage, which has no physiologic basis
Monitoring Challenges
- If hypoglycemia occurs, determining which insulin to adjust becomes problematic
- Dose titration becomes unnecessarily complex
Common Pitfall to Avoid
Do not add basal insulins together. If one basal insulin is insufficient, the solution is to:
- Increase the dose of the existing basal insulin
- Add prandial insulin for meal coverage
- Consider adjunctive therapy (GLP-1 RA, SGLT2 inhibitor) 2
- Switch to a different basal insulin if there are specific issues (e.g., hypoglycemia with NPH → switch to Lantus)
The evidence consistently shows that basal insulins (whether NPH, glargine, or detemir) are used as alternatives to each other, not in combination 1, 3, 4, 5.